Cargando…

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization

The presence of anti-HLA antibodies is an increasing challenge in kidney transplantation. Tocilizumab (TCZ), a monoclonal antibody targeting the interleukin-6 receptor (IL-6R), has been proposed to complement conventional desensitization therapy. We aimed to describe TCZ plasma trough concentrations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Truffot, Aurélie, Jouve, Thomas, Noble, Johan, Bardy, Béatrice, Malvezzi, Paolo, Rostaing, Lionel, Stanke-Labesque, Françoise, Gautier-Veyret, Elodie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745611/ https://www.ncbi.nlm.nih.gov/pubmed/35011830 http://dx.doi.org/10.3390/jcm11010091

Ejemplares similares

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
por: Arrivé, Capucine, et al.
Publicado: (2023)

Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review
por: Weinhard, Jules, et al.
Publicado: (2021)

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study
por: Jouve, Thomas, et al.
Publicado: (2023)

Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
por: Bolcato, Léa, et al.
Publicado: (2022)

Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation?
por: Chavant, Anaelle, et al.
Publicado: (2021)

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates
por: Daligault, Mélanie, et al.
Publicado: (2021)

Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
por: Stanke-Labesque, Françoise, et al.
Publicado: (2020)

Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data
por: Bolcato, Léa, et al.
Publicado: (2021)

Modifications pharmacocinétiques liées à une infection aiguë. Exemples issus de la pandémie de SARS-CoV-2
por: Chavant, Anaëlle, et al.
Publicado: (2021)

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
por: Cabezas, Lara, et al.
Publicado: (2022)

Immortal Time-Bias–Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients
por: Noble, Johan, et al.
Publicado: (2021)

Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological Monitoring
por: Noble, Johan, et al.
Publicado: (2021)

Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study
por: Vela, Carla, et al.
Publicado: (2022)

Transplantation of Marginal Organs: Immunological Aspects and Therapeutic Perspectives in Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2020)

Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series
por: Naciri Bennani, Hamza, et al.
Publicado: (2019)

Kidney Transplantation for Focal Segmental Glomerulosclerosis: Can We Prevent Its Recurrence? Personal Experience and Literature Review
por: Naciri Bennani, Hamza, et al.
Publicado: (2021)

Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response
por: Terrec, Florian, et al.
Publicado: (2021)

Place of mTOR inhibitors in management of BKV infection after kidney transplantation
por: Jouve, Thomas, et al.
Publicado: (2016)

Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
por: Malvezzi, Paolo, et al.
Publicado: (2015)

Costimulation Blockade in Kidney Transplantation: An Update
por: Malvezzi, Paolo, et al.
Publicado: (2016)

Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?
por: Malvezzi, Paolo, et al.
Publicado: (2018)

Cryoglobulinemia and double‐filtration plasmapheresis: Personal experience and literature review
por: Naciri Bennani, Hamza, et al.
Publicado: (2022)

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2021)

Neglecting Plasma Protein Binding in COVID‐19 Patients Leads to a Wrong Interpretation of Lopinavir Overexposure
por: Stanke‐Labesque, Francoise, et al.
Publicado: (2021)

Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm Study
por: Jouve, Thomas, et al.
Publicado: (2022)

Very Early Severe Posttransplant Recurrent Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Kidney Transplantation: Two Case Reports
por: Laamech, Reda, et al.
Publicado: (2022)

Protocol Biopsies on de novo Renal-Transplants at 3 Months after Surgery: Impact on 5-Year Transplant Survival
por: Terrec, Florian, et al.
Publicado: (2021)

Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates
por: Rostaing, Lionel, et al.
Publicado: (2016)

Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
por: Terrec, Florian, et al.
Publicado: (2019)

Leukotriene Production Is Increased in Abdominal Obesity
por: Bäck, Magnus, et al.
Publicado: (2014)

Steroid-Based Therapy and Risk of Infectious Complications
por: Rostaing, Lionel, et al.
Publicado: (2016)

Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

Of waves and troughs
por: Noll-Hussong, Michael
Publicado: (2014)

B cell repertoires in HLA-sensitized kidney transplant candidates undergoing desensitization therapy
por: Beausang, John F., et al.
Publicado: (2017)

Immune Response Post–SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept
por: Noble, Johan, et al.
Publicado: (2021)

Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies
por: Perrier, Quentin, et al.
Publicado: (2021)

Street Troughs and Glanders
Publicado: (1892)

Danger in the Water Trough
Publicado: (1885)

Opioid receptor desensitization: mechanisms and its link to tolerance
por: Allouche, Stéphane, et al.
Publicado: (2014)

NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users
por: Willeman, Théo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nr62v4vlkjrqbtk517ja7mjduc